IP Verse

Neurocrine Biosciences, Inc. - PGR2026-00059

Explore the PTAB proceeding PGR2026-00059 filed by Neurocrine Biosciences, Inc. on Jun 18, 2026. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: PGR2026-00059
Filing Date: Jun 18, 2026
Petitioner: Neurocrine Biosciences, Inc.
Status: Petition filed
Respondent Application Number: 19043275
Respondent Tech Center: 1600
Respondent Patent Number: 12569491

Decision Documents New

Decision documents related to this case provide insights into the outcomes of proceedings. These documents are crucial for understanding the legal determinations and implications for the parties involved.

Document Name	Filing Date	Category	Filing Party
Final Written Decision, Paper 64, PGR2021-00088	Jun 18, 2026	EXHIBIT	PETITIONER
Final Written Decision, Paper 62, No. PGR2022-00025	Jun 18, 2026	EXHIBIT	PETITIONER
Decision of EPO Opposition Division, revoking EP 3 784 233, Dec. 12, 2025	Jun 18, 2026	EXHIBIT	PETITIONER
Director Review Decision in PGR2021-00088, Paper 66	Jun 18, 2026	EXHIBIT	PETITIONER
Director Review Decision in PGR2022-00025, Paper 64	Jun 18, 2026	EXHIBIT	PETITIONER

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice: Power of Attorney	Jun 18, 2026	PAPER	PETITIONER
U.S. Patent No. 12,569,491 to Howerton et al.	Jun 18, 2026	EXHIBIT	PETITIONER
Prosecution History of the ‘491 Patent (“the Prosecution History”)	Jun 18, 2026	EXHIBIT	PETITIONER
PCT Publication WO/2015/112642 to Grigoriadis et al.	Jun 18, 2026	EXHIBIT	PETITIONER
Final Written Decision, Paper 64, PGR2021-00088	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Publication No. 2017/0020877 to Grigoriadis et al.	Jun 18, 2026	EXHIBIT	PETITIONER
Final Written Decision, Paper 62, No. PGR2022-00025	Jun 18, 2026	EXHIBIT	PETITIONER
Turcu 2016	Jun 18, 2026	EXHIBIT	PETITIONER
CRENESSITY (crinecerfont) Prescribing Label, Dec 13, 2024	Jun 18, 2026	EXHIBIT	PETITIONER
Neurocrine Biosciences, Inc., Q4 2025 Earnings Release	Jun 18, 2026	EXHIBIT	PETITIONER
Speiser 2010	Jun 18, 2026	EXHIBIT	PETITIONER
Turcu & Auchus 2015	Jun 18, 2026	EXHIBIT	PETITIONER
El Maouche 2017	Jun 18, 2026	EXHIBIT	PETITIONER
Merke & Bornstein 2005	Jun 18, 2026	EXHIBIT	PETITIONER
Speiser 2018	Jun 18, 2026	EXHIBIT	PETITIONER
Fahmy 2017	Jun 18, 2026	EXHIBIT	PETITIONER
Griebel 2002	Jun 18, 2026	EXHIBIT	PETITIONER
Gully 2002	Jun 18, 2026	EXHIBIT	PETITIONER
European Pat. No. 3 784 233 to Alexis Howerton, et al.	Jun 18, 2026	EXHIBIT	PETITIONER
Merke & Auchus 2020	Jun 18, 2026	EXHIBIT	PETITIONER
Turcu & Auchus 2016	Jun 18, 2026	EXHIBIT	PETITIONER
Webb & Krone 2015	Jun 18, 2026	EXHIBIT	PETITIONER
Neurocrine March 20, 2021 Press Release	Jun 18, 2026	EXHIBIT	PETITIONER
Decision of EPO Opposition Division, revoking EP 3 784 233, Dec. 12, 2025	Jun 18, 2026	EXHIBIT	PETITIONER
Williams 2013	Jun 18, 2026	EXHIBIT	PETITIONER
Director Review Request in PGR2021-00088, Paper 65	Jun 18, 2026	EXHIBIT	PETITIONER
Director Review Request in PGR2022-00025, Paper 63	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 5282340, Crinecerfont 2026	Jun 18, 2026	EXHIBIT	PETITIONER
Director Review Decision in PGR2021-00088, Paper 66	Jun 18, 2026	EXHIBIT	PETITIONER
Director Review Decision in PGR2022-00025, Paper 64	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Patent No. 10,849,908 to Alexis Howerton et al.	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Patent No. 11,007,201 to Alexis Howerton et al.	Jun 18, 2026	EXHIBIT	PETITIONER
Zaarour 2014	Jun 18, 2026	EXHIBIT	PETITIONER
Sarafoglou 2023	Jun 18, 2026	EXHIBIT	PETITIONER
Chen 2017	Jun 18, 2026	EXHIBIT	PETITIONER
Sarafoglou 2021	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Pat. No. 11,304,950 to Alexis Howerton et al.	Jun 18, 2026	EXHIBIT	PETITIONER
Spruce March 25, 2019, Press Release	Jun 18, 2026	EXHIBIT	PETITIONER
Spruce March 13, 2024, Press Release	Jun 18, 2026	EXHIBIT	PETITIONER
Spruce December 10, 2024, Press Release	Jun 18, 2026	EXHIBIT	PETITIONER
Turcu & Auchus 2015	Jun 18, 2026	EXHIBIT	PETITIONER
Mallappa & Merke	Jun 18, 2026	EXHIBIT	PETITIONER
Auchus 2022	Jun 18, 2026	EXHIBIT	PETITIONER
Claahsen-van der Grinten 2022	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Pat. 11,304,950 Request and COC issued June 17, 2025	Jun 18, 2026	EXHIBIT	PETITIONER
PCT/US2019/029486	Jun 18, 2026	EXHIBIT	PETITIONER
Auchus 2024	Jun 18, 2026	EXHIBIT	PETITIONER
Sarafoglou et al. 2024	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Provisional App. No. 62/663,951 (the “’951 provisional”)	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Provisional App. No. 62/822,815 (the “’815 provisional”)	Jun 18, 2026	EXHIBIT	PETITIONER
Neurocrine July 1, 2024, Press Release	Jun 18, 2026	EXHIBIT	PETITIONER
Dec. 13, 2024, Neurocrine Press Release	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 134694266, Tildacerfont 2026	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. Pat. No. 6,586,456 to Fontaine, et al.	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. App No. 17/081,694, OAR with Chris Barnes Declaration Dec. 13, 2021	Jun 18, 2026	EXHIBIT	PETITIONER
Delfino 2012	Jun 18, 2026	EXHIBIT	PETITIONER
Yu 2015	Jun 18, 2026	EXHIBIT	PETITIONER
Aycan 2013	Jun 18, 2026	EXHIBIT	PETITIONER
Claahsen-van der Grinten 2021	Jun 18, 2026	EXHIBIT	PETITIONER
Reisch 2013	Jun 18, 2026	EXHIBIT	PETITIONER
Mendes-dos-Santos 2018	Jun 18, 2026	EXHIBIT	PETITIONER
Spruce Biosciences Clinical Study Report, SPR001-202 Protocol 2025	Jun 18, 2026	EXHIBIT	PETITIONER
International Publication No. WO 2016/065177 A1 to Howerton et al.	Jun 18, 2026	EXHIBIT	PETITIONER
GSK Study	Jun 18, 2026	EXHIBIT	PETITIONER
Wilson 2001	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. App. No. 17/081,694, NOA & Reasons for Allowance, Feb 1, 2022	Jun 18, 2026	EXHIBIT	PETITIONER
Smeets 2015	Jun 18, 2026	EXHIBIT	PETITIONER
Claahsen-van der Grinten 2009	Jun 18, 2026	EXHIBIT	PETITIONER
O’Shea 2019	Jun 18, 2026	EXHIBIT	PETITIONER
Tellew 2010	Jun 18, 2026	EXHIBIT	PETITIONER
Chen 2008	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. App. No. 18/941,832 Preliminary amendment filed 5 February 2026	Jun 18, 2026	EXHIBIT	PETITIONER
U.S. App. No. 18/438,060 Claim Amendments Filed 3 April 2026	Jun 18, 2026	EXHIBIT	PETITIONER
Declaration of June Ann Munford (May 22, 2026)	Jun 18, 2026	EXHIBIT	PETITIONER
FDA News Release, December 13, 2024	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 11596613, Verucerfont 2026	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 24758885, 2026	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 24898976, 2026	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 9821250, NBI-30775, 2026	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 9888194, NBI-34041, 2026	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 9884878, DMP-904, 2026	Jun 18, 2026	EXHIBIT	PETITIONER
PubChem Compound Summary for CID 177990, Antalarmin 2026	Jun 18, 2026	EXHIBIT	PETITIONER
NCT04457336, ClinicalTrials.gov., Spruce Biosciences	Jun 18, 2026	EXHIBIT	PETITIONER
Newfield 2023	Jun 18, 2026	EXHIBIT	PETITIONER
PGR2025-00032, Paper 2	Jun 18, 2026	EXHIBIT	PETITIONER
PGR2025-00032, Paper 8	Jun 18, 2026	EXHIBIT	PETITIONER
Declaration of Ramesh Tharuvai, Ph.D.	Jun 18, 2026	EXHIBIT	PETITIONER
Declaration of Maya Lodish, M.D.	Jun 18, 2026	EXHIBIT	PETITIONER
Petition: as filed	Jun 18, 2026	PAPER	PETITIONER